Literature DB >> 17542673

Appetite regulation: an overview.

Waljit S Dhillo1.   

Abstract

Obesity is a major public health problem associated with morbidity and mortality and continues to increase worldwide. This review focuses on the regions of the brain that are important in appetite regulation and the circulating factors implicated in the control of food intake. The hypothalamus is critical in the regulation of food intake containing neural circuits, which produce a number of peptides that influence food intake. The arcuate nucleus of the hypothalamus produces both orexigenic peptides (agouti-related protein and neuropeptide Y) and anorectic peptides (alpha-melanocyte-stimulating hormone and cocaine- and amphetamine-related transcript). The lateral hypothalamus produces the orexigenic peptides (melanin-concentrating hormone and orexins). Other hypothalamic factors recently implicated in appetite regulation include the endocannabinoids, brain-derived neurotrophic factor, nesfatin-1, AMP-activated protein kinase, mammalian target of rapamycin protein, and protein tyrosine phosphatase. Circulating factors that affect food intake mediate their effects by signaling to the hypothalamus and/or brainstem. A number of circulating factors are produced by peripheral organs, for example, leptin by adipose tissue, insulin and pancreatic polypeptide by the pancreas, gut hormones (e.g., ghrelin, obestatin, glucagon-like peptide-1, oxyntomodulin, peptide YY), and triiodothyronine by the thyroid gland. Circulating carbohydrates, lipids, and amino acids also affect appetite regulation. Knowledge regarding appetite regulation has vastly expanded in recent years providing targets for antiobesity drug design.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542673     DOI: 10.1089/thy.2007.0018

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  36 in total

Review 1.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

Review 2.  Mechanisms limiting body growth in mammals.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Endocr Rev       Date:  2011-03-25       Impact factor: 19.871

3.  Leptin signaling modulates the activity of urocortin 1 neurons in the mouse nonpreganglionic Edinger-Westphal nucleus.

Authors:  Lu Xu; Wim J J M Scheenen; Rebecca L Leshan; Christa M Patterson; Carol F Elias; Sanne Bouwhuis; Eric Willem Roubos; Martin G Myers; Tamás Kozicz
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

Review 4.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

5.  Peripheral blood mononuclear cells: a potential source of homeostatic imbalance markers associated with obesity development.

Authors:  Paula Oliver; Bàrbara Reynés; Antoni Caimari; Andreu Palou
Journal:  Pflugers Arch       Date:  2013-02-20       Impact factor: 3.657

Review 6.  Multi-functional peptide hormone NUCB2/nesfatin-1.

Authors:  Suleyman Aydin
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

7.  Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.

Authors:  Erin Golden; Ana Emiliano; Stuart Maudsley; B Gwen Windham; Olga D Carlson; Josephine M Egan; Ira Driscoll; Luigi Ferrucci; Bronwen Martin; Mark P Mattson
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

8.  The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.

Authors:  Martina von Wilmsdorff; Marie-Luise Bouvier; Uwe Henning; Andrea Schmitt; Wolfgang Gaebel
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

9.  Molecular therapy of obesity and diabetes by a physiological autoregulatory approach.

Authors:  Lei Cao; En-Ju D Lin; Michael C Cahill; Chuansong Wang; Xianglan Liu; Matthew J During
Journal:  Nat Med       Date:  2009-03-08       Impact factor: 53.440

10.  Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus.

Authors:  Ernest Adeghate; Maria Fernandez-Cabezudo; Rashed Hameed; Hussain El-Hasasna; Mohamed El Wasila; Tariq Abbas; Basel Al-Ramadi
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.